Our limit order for Rubrik was executed. We bought 250 shares at $92.99. We now have 1200 shares. The purchase cost $23,255. The new weight of Rubrik in the portfolio is now about 7.6%. To offset the purchase we sold the remaining Nutanix in the portfolio. We sold 250 shares of Nutanix at $76.22. This…
Shares of Rubrik spiked a little this morning and I got off a sale of 300 shares at my limit of $96.99. I had tried for more, but this was the best price at which I got a fill. Investors-or dare I say traders have been very picky with how they react to earnings. Shares of both…
AS we had discussed in this week’s commentary, we believed that the recent appreciation of IT stocks had taken some of the positions in the portfolio to valuations that were a bit stressed. Today, that opinion was seconded by the analyst team at Raymond James with regards to Nutanix. That precipitated our sale of a…
Yesterday afternoon was a tense time for holders of high growth IT stocks. Would Nvidia confirm what most implicitly believed with regards to GPU chips? Or was the bloom off the rose. Happy to say, the rose is still in all of its June glory-well roses used to reach peak bloom in this climate in…
A very busy week for earnings. I am going to try to cover results and guidance of the companies in the high growth portfolio that have reported these last couple of days. There obviously have been other earnings reports of interest. In particular, Nvidia’s earnings release and forward guidance were not enough of a beat…
SummaryNutanix has become a company generating substantial free cash flow as well as strong revenue growth. Nutanix shares have experienced significant volatility, with recent drops in value due to market sentiment and cautious guidance. The company is a market leader in hyper-converged solutions and is expanding its product offerings beyond HCI. Despite challenges, Nutanix is…
Sale of 150 shares of Dynatrace (remaining position); Purchase of 30 shares of Datadog; Purchase of 150 shares of Nutanix. Dynatrace: We eliminated the last of our Dynatrace (DT) position this morning. We were sorry to have to eliminate the position, but at this point the growth divergence between Dynatrace and Datadog was just too great to…
Sales of 1500 shares of UiPath and Sale of 150 shares of Dynatrace: Purchase of 300 shares of Nutanix, Purchase of 200 shares of GitLab As we had indicated, we have now eliminated UiPath from the portfolio. Its latest earnings report and guidance were very disappointing, and while the narrative may play out, we simply…
UiPath; Nutanix, Pure and Salesforce It’s Thursday, the trading week is half over and there are some notable casualties. UiPath is trading down by about 34% and Salesforce is down by more than 18%. NTNX, which had been “bulled-up” into the numbers, is trading in line with a “sell the news paradigm” and is down…
Purchase of 60 shares of Snowflake; Sale of 150 shares of Nutanix We added 50 shares of Snowflake (SNOW) to our high growth portfolio today. We previously had 270 shares and we now have 330 shares. At the current price, a 330 share position is a weighting of about 5%. Snowflake shares, after spiking positively…